Autres langues Acarix AB Deutsche Boerse AG

Actions

7AC

SE0009268717

Marché Fermé - Deutsche Boerse AG Autres places de cotation 09:59:34 21/06/2024			Varia. 5j.	Varia. 1 janv.
0,0222 ^EUR	-19,57%		-23,45%	+46,05%

11/06	Acarix annonce le recrutement du premier patient dans le cadre d'une étude clinique d'évaluation du flux de travail aux États-Unis	CI
27/05	Acarix AB (Publ) nomme Jeff Thomas a la tete des ventes aux Etats-Unis, a compter du 1er juin 2024	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Acarix announces enrollment of first patient in US-based Clinical Workflow Evaluation Study	11/06
Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study	11/06
Acarix welcomes Jeff Thomas as new Head of US Sales	27/05
Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	27/05
Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List	20/05
Acarix Q1 2024 - Soft sales but strong outlook	15/05
Announcement from the annual general meeting in Acarix AB	14/05
Acarix AB Approves Board Elections	14/05
Acarix AB (publ) publishes Interim Report, January – March 2024	14/05
Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida	13/05
Acarix Secures Multi-Unit Order from Major Cardiology Practice with Several Offices in Florida	13/05
Invitation to presentation of Acarix´s first quarter report	10/05
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region	06/05
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)	03/05
Acarix receives order from the first freestanding Emergency Room in the US	29/04
Acarix Receives Order from the First Freestanding Emergency Room in the Us	29/04
Acarix AB’s Annual Report 2023	23/04
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB	11/04
Acarix announces the initiation of the first US-based clinical workflow evaluation study	11/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Acarix AB Deutsche Boerse AG

Actions

7AC

SE0009268717

Autres langues

Filtres